Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy
Clinical trial NCT03700905 · UNKNOWN
Trial details
- NCT number
- NCT03700905
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-21
- Primary completion
- 2024-05-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.